Meropenem is a broad-spectrum carbapenem antibiotic used to treat a variety of bacterial infections [1]. It is administered intravenously [2].
How does meropenem work?
Meropenem functions by inhibiting bacterial cell wall synthesis [1]. It penetrates bacterial cell walls and binds to penicillin-binding proteins (PBPs), which are essential enzymes involved in the final stages of peptidoglycan synthesis. This binding inactivates the PBPs, preventing the cross-linking of peptidoglycan chains and leading to cell wall weakening and eventual bacterial lysis [1].
What kinds of infections is meropenem used for?
Meropenem is effective against a wide range of Gram-positive and Gram-negative bacteria, including many that are resistant to other antibiotics [1]. It is commonly prescribed for serious infections such as:
* Pneumonia, including hospital-acquired pneumonia [1]
* Intra-abdominal infections [1]
* Complicated urinary tract infections [1]
* Complicated skin and soft tissue infections [1]
* Bacterial meningitis [1]
* Sepsis [1]
* Febrile neutropenia, a condition where individuals with low white blood cell counts develop a fever [1]
How is meropenem administered?
Meropenem is given through intravenous (IV) injection or infusion [2]. This method ensures rapid and direct delivery of the antibiotic into the bloodstream, allowing it to reach the site of infection effectively [2].
What are the potential side effects of meropenem?
Common side effects associated with meropenem include nausea, vomiting, diarrhea, constipation, headache, and rash [3]. More serious, though less frequent, side effects can include allergic reactions, seizures, and C. difficile-associated diarrhea [3].
Are there different brands of meropenem available?
Meropenem is available as a generic medication, and various pharmaceutical companies manufacture it under different brand names [4]. Examples include Merrem and Meropenem-Jian, among others [4].
What is the patent status of meropenem?
Meropenem has been available for some time, and its original patents have expired in most major markets [5]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including meropenem, which can indicate when market exclusivity may end for specific formulations or applications [5]. The expiration of primary patents typically opens the door for the development and marketing of generic versions [5].